BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 31106639)

  • 41. Antimicrobial Emulsifier-Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis, and Systemic Low-Grade Inflammation in Low-Fat Diet Fed Mice.
    Jiang Z; Zhao M; Zhang H; Li Y; Liu M; Feng F
    Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29131494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Impact of Chronic Intestinal Inflammation on Brain Disorders: the Microbiota-Gut-Brain Axis.
    Serra D; Almeida LM; Dinis TCP
    Mol Neurobiol; 2019 Oct; 56(10):6941-6951. PubMed ID: 30945157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sleep Deprivation and Gut Microbiota Dysbiosis: Current Understandings and Implications.
    Sun J; Fang D; Wang Z; Liu Y
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy-induced peripheral neuropathy.
    Fehrenbacher JC
    Prog Mol Biol Transl Sci; 2015; 131():471-508. PubMed ID: 25744683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy.
    Chen X; Gan Y; Au NPB; Ma CHE
    Front Mol Neurosci; 2024; 17():1345811. PubMed ID: 38660386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exercise and immune system as modulators of intestinal microbiome: implications for the gut-muscle axis hypothesis.
    Ticinesi A; Lauretani F; Tana C; Nouvenne A; Ridolo E; Meschi T
    Exerc Immunol Rev; 2019; 25():84-95. PubMed ID: 30753131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Gut Microbiome as a Regulator of the Neuroimmune Landscape.
    Yu LW; Agirman G; Hsiao EY
    Annu Rev Immunol; 2022 Apr; 40():143-167. PubMed ID: 34990209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A potential role for the gut microbiome in substance use disorders.
    Meckel KR; Kiraly DD
    Psychopharmacology (Berl); 2019 May; 236(5):1513-1530. PubMed ID: 30982128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.
    Aguilera M; Cerdà-Cuéllar M; Martínez V
    Gut Microbes; 2015; 6(1):10-23. PubMed ID: 25531553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
    Bruneau A; Baylatry MT; Joly AC; Sokol H
    Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease.
    Chi Y; Lin Y; Lu Y; Huang Q; Ye G; Dong S
    Sci Total Environ; 2019 Feb; 653():274-282. PubMed ID: 30412872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure.
    Sata Y; Marques FZ; Kaye DM
    Curr Hypertens Rep; 2020 May; 22(5):38. PubMed ID: 32385705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction between gut microbiota and ethnomedicine constituents.
    Wu XM; Tan RX
    Nat Prod Rep; 2019 May; 36(5):788-809. PubMed ID: 30534698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of mucositis in predicting gut microbiota composition in people with cancer.
    Scott JS; Li A; Wardill HR
    Curr Opin Support Palliat Care; 2024 Jun; 18(2):73-77. PubMed ID: 38652454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotherapy-induced peripheral neuropathy: a review of recent findings.
    Kim PY; Johnson CE
    Curr Opin Anaesthesiol; 2017 Oct; 30(5):570-576. PubMed ID: 28708674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of vitamin D on gut microbiota in cystic fibrosis.
    Kanhere M; Chassaing B; Gewirtz AT; Tangpricha V
    J Steroid Biochem Mol Biol; 2018 Jan; 175():82-87. PubMed ID: 27818276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut microbiota and host defense in critical illness.
    Jacobs MC; Haak BW; Hugenholtz F; Wiersinga WJ
    Curr Opin Crit Care; 2017 Aug; 23(4):257-263. PubMed ID: 28548992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.